IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIAGIOLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.703
AS - Asia 2.759
EU - Europa 2.178
SA - Sud America 423
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 74
OC - Oceania 8
Totale 10.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.433
SG - Singapore 1.220
IT - Italia 689
CN - Cina 458
IE - Irlanda 357
RU - Federazione Russa 321
HK - Hong Kong 312
BR - Brasile 308
VN - Vietnam 274
FR - Francia 153
DE - Germania 145
CA - Canada 131
BD - Bangladesh 107
GB - Regno Unito 98
FI - Finlandia 87
KR - Corea 70
IN - India 59
SE - Svezia 56
UA - Ucraina 49
PL - Polonia 46
TR - Turchia 40
AT - Austria 38
IQ - Iraq 38
AR - Argentina 37
MX - Messico 35
NL - Olanda 32
ZA - Sudafrica 28
JP - Giappone 27
ES - Italia 23
EC - Ecuador 22
PK - Pakistan 21
SA - Arabia Saudita 21
ID - Indonesia 20
BE - Belgio 19
CR - Costa Rica 18
CH - Svizzera 15
CO - Colombia 15
SV - El Salvador 15
VE - Venezuela 14
IL - Israele 12
JM - Giamaica 12
UZ - Uzbekistan 12
UY - Uruguay 11
PR - Porto Rico 10
CW - ???statistics.table.value.countryCode.CW??? 9
GT - Guatemala 9
MA - Marocco 9
LB - Libano 8
NI - Nicaragua 8
HN - Honduras 7
MY - Malesia 7
SC - Seychelles 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
LT - Lituania 6
PH - Filippine 6
PY - Paraguay 6
AU - Australia 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
EE - Estonia 4
GP - Guadalupe 4
GR - Grecia 4
TN - Tunisia 4
BZ - Belize 3
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BS - Bahamas 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
Totale 10.129
Salva come PNG Salva come JPEG
Città #
Singapore 929
Ashburn 522
Chandler 501
San Jose 459
Dublin 351
Hong Kong 311
Perugia 247
San Mateo 196
Santa Clara 182
Council Bluffs 158
Moscow 118
Boardman 113
Beijing 104
Dong Ket 96
Los Angeles 94
Lauterbourg 93
Ann Arbor 85
New York 83
Princeton 80
Medford 76
Seoul 68
Altamura 63
Munich 60
São Paulo 57
Ho Chi Minh City 54
Wilmington 53
Lawrence 52
Hanoi 50
Dallas 46
Warsaw 42
Dearborn 41
Andover 37
North Bergen 36
Brooklyn 35
Toronto 33
Montreal 32
Orem 31
Piscataway 30
Phoenix 29
Rome 29
Helsinki 28
Turku 27
Milan 26
Tokyo 26
Houston 23
Redmond 23
Chicago 21
Atlanta 20
Vienna 20
Denver 19
Brussels 18
Buffalo 18
Johannesburg 18
Redwood City 18
Florence 17
The Dalles 17
Baghdad 16
Hefei 16
London 16
Norwalk 16
Nuremberg 16
Saint Petersburg 16
San José 16
Stockholm 16
Amsterdam 15
Charlotte 15
Frankfurt am Main 15
Naples 15
Bologna 14
Chennai 14
Mexico City 13
Poplar 13
San Salvador 13
Shanghai 13
San Francisco 12
Seattle 11
Calgary 10
Columbus 10
New Orleans 10
Philadelphia 10
Vicenza 10
Ankara 9
Guayaquil 9
Quito 9
Riyadh 9
Brasília 8
Den Haag 8
Des Moines 8
Lahore 8
Lappeenranta 8
Riverbank 8
Willemstad 8
Cambridge 7
Dhaka 7
Istanbul 7
Jeddah 7
Managua 7
Manchester 7
New Delhi 7
Querétaro 7
Totale 6.504
Salva come PNG Salva come JPEG
Nome #
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 164
Glucocorticoid and B cell development: role of Glucocorticoid-induced leucine zipper 156
LACK OF GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) RESULTS IN B CELL LYMPHOPROLIFERATIVE DISORDER IN MICE 147
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 144
Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment 143
Wnt/beta-Catenin Signaling Induces Integrin alpha 4 beta 1 in T Cells and Promotes a Progressive Neuroinflammatory Disease in Mice 142
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 134
GILZ REGULATES PRODUCTION OF PTREG AND TTREG CELLS AND IS NECESSARY FOR GLUCOCORTICOID-MEDIATED INDUCTION OF TREG CELLS 133
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 129
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 125
GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling 124
Glucocorticoid indeced lLeucine Zipper protein (GILZ) regulates Hematopoietic stem cell engrafment and myeloid differentiation in a mouse model of CEBPA mutant acute myeloid leukemia 123
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 123
Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice 122
Role of GILZ in mediating the anti-inflammatory actions of glucocorticoids 121
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 120
Long- Glucocrticoid induced Leucine Zipper interacts with Ras pathway and is essential for spermatogenesis 119
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 119
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 119
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 119
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 118
Bile Acid Signaling in Inflammatory Bowel Diseases 117
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 116
GILZ regulates the development of Treg cells via regulation of crosstalk between Glucocorticoids and TGF-beta 115
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 114
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 114
Glucocorticoid-induced leucine Zipper (GILZ) anf the new isoform L-GILZ mediates the anti-inflammatory effects of glucocorticoids 112
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 112
Glucocorticoid-induced leucine Zipper (GILZ) controls T lymphocytes differentation 111
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 110
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 110
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 110
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 109
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 109
Bile Acids Activated Receptors Regulate innate immunity 107
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 107
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 105
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 105
Bile acids and their receptors in hepatic immunity 105
Bile Acids Activated Receptors in Inflammatory Bowel Disease 105
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 104
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 104
Glucocorticoid-induced leucine zipper (GILZ) is involved in Th2-mediated oxazolone-induced colitis 103
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 103
Bile acids and bile acid activated receptors in the treatment of Covid-19 102
The effect of Ara-C treatment on hematopoietic stem cell expasion and leukemogenesis in a mouse model of CEBPA mutant acute myeloid leukemia 102
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 102
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 102
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 101
Glucocorticoid-induced leucine zipper (GILZ) is a regulator of intestina immune homeostatsis and anti-inflammatory effects of glucocorticoids 100
Bile acids and their receptors in metabolic disorders 100
Long-glucocorticoid-induced leucine zipper (L-GILZ) expression as a new diagnostic biomarker for male infertility associated with exposure to electromagnetic fields and radiofrequency radiation. 99
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 99
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 98
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH) 98
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 97
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 96
Recombinant long-Glucocorticoid-induced leucine zipper (L-GILZ) protein restores the control of proliferation in gilz KO spermatogonia 96
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 96
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 95
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 94
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 94
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 94
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 93
REGULATION OF HEMATOPOIETIC STEM CELL (HSC) DEVELOPMENT: ROLE OF GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) 92
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 90
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 90
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 90
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 85
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 85
The identification of farnesoid X receptor modulators as treatment options for non-alcoholic fatty liver disease 85
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 84
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 83
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity 83
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 82
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 82
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease 82
Glucocorticoid-Induced Leucine Zipper (GILZ) controls inflammation and tissue damage after spinal cord injury. 81
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 80
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 80
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 80
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 78
Modeling Inflammatory Bowel Disease by Intestinal Organoids 77
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 76
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 76
Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis 75
Immunomodulatory functions of FXR 75
Immunology of bile acids regulated receptors 73
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 73
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 71
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 69
Future trends in the treatment of non-alcoholic steatohepatitis 69
BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile 67
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments 67
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 67
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics 66
Sa1931 – Physico-Chemistry, Proteomics and In Vivo Comparative Tests to Reveal Variability in Multistrain Probiotic Formulations 65
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 63
Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists 62
Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis 61
Totale 9.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022494 0 0 0 0 14 6 38 175 15 69 88 89
2022/20231.378 90 242 14 124 132 123 2 82 495 3 55 16
2023/2024563 31 48 20 17 22 3 141 31 31 20 122 77
2024/20251.628 21 139 87 77 151 126 116 131 315 78 268 119
2025/20263.918 238 248 189 556 578 325 570 180 398 358 158 120
2026/20271.397 117 150 204 789 137 0 0 0 0 0 0 0
Totale 10.444